Nuburu
Nuburu's revenue fell 100.0% to $0 million in fiscal 2025. Free cash flow was −$21 million. The diluted share count rose 2628.0%.
Net margin is net income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Income statement
Nuburu lost money in fiscal 2025: a net loss of $79 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 0 | 3 | 2 | 0 | 25 |
| Debt incl. finance leases | — | 23 | 9 | 9 | 26 |
| Net debt (negative means net cash) | — | 20 | 7 | 9 | 1 |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | — | −79.9x | −25.1x | −3.9x | −38.9x |
| Current ratio | 0.1x | 0.3x | 0.4x | 0.1x | 0.8x |
| Quick ratio | 0.1x | 0.2x | 0.3x | 0.0x | — |
Cash flow
Projections
Project Nuburu's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 1 insider bought $1.5 million of Nuburu shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | Alessandro ZamboniCo-Chief Executive Officer, Director | Bought | 4,332,525 | $0.35 | $1.5 million | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 4 of 9 | 2 of 9 | 3 of 8 |
| Rule of 40 | −852.2% | — | — |
| Altman Z'' | −49.03 | −94.01 | −17.90 |
| Accruals ratio | −26.8% | −318.2% | −221.8% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Fail | Fail | Fail |
| Return on assets rose | Fail | Fail | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Pass |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Fail | Pass | Fail |
| Gross margin rose | Pass | Fail | — |
| Revenue rose relative to assets | Pass | Fail | Fail |
| F-score | 4 of 9 | 2 of 9 | 3 of 8 |
Compare
Put Nuburu side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Nuburu | FY25 | −100.0% | — | — | — | — | 3 | |
| Allient | FY25 | 4.6% | 7.9% | 9.0% | 7.4% | 2.1x | 7 | Compare |
| Ametek | FY25 | 6.6% | 25.8% | 22.6% | 13.2% | 0.8x | 7 | Compare |
| Amprius Technologies | FY25 | 202.1% | −63.9% | −48.7% | — | — | — | Compare |
| American Superconductor | FY26 | 34.3% | 3.8% | 6.1% | 4.3% | −7.5x | 6 | Compare |
5 years of figures
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | 1 | 2 | 0 | 0 |
| Revenue growth | — | — | 44.8% | −92.7% | −100.0% |
| Gross profit | — | −3 | −4 | −2 | −0 |
| Research and development | — | 4 | 6 | 2 | 0 |
| Operating income | −6 | −14 | −22 | −13 | −18 |
| Net income | 18 | −30 | −21 | −34 | −79 |
| Diluted EPS (US$) | — | −27.05 | −3.15 | −29.51 | −2.25 |
| Diluted shares (millions) | — | 1 | 7 | 1 | 32 |
| Cash flow | |||||
| Cash from operations | −2 | −10 | −18 | −7 | −16 |
| Capital expenditure | — | 0 | 1 | — | 5 |
| Free cash flow | — | −11 | −19 | — | −21 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 303 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | — | 2 | 2 | 2 | 2 |
| Balance sheet at fiscal year end | |||||
| Cash and short-term investments | 0 | 3 | 2 | 0 | 25 |
| Debt incl. finance leases | — | 23 | 9 | 9 | 26 |
| Total assets | 335 | 13 | 11 | 7 | 50 |
| Total liabilities | 29 | 30 | 19 | 21 | 65 |
| Shareholders' equity | 10 | −17 | −32 | −38 | −15 |
| Margins and ratios | |||||
| Gross margin | — | −237.4% | −173.1% | −1,349.8% | — |
| Operating margin | — | −971.8% | −1,041.9% | −8,644.7% | — |
| Net margin | — | −2,049.2% | −993.0% | −22,688.8% | — |
| Free cash flow margin | — | −747.3% | −897.0% | — | — |
| Rule of 40 (growth + FCF margin) | — | — | −852.2% | — | — |
| Return on capital | — | — | — | — | — |
| Return on equity | — | — | — | — | — |
| Return on assets | — | −17.0% | −174.9% | −393.7% | −278.5% |
| Net debt to EBITDA | — | — | — | — | — |